Terminated NA INTERVENTIONAL 4-arm NCT05832190

Correcting GUT MicrobioTa by Combined Supplementation of FibERs and BIotiN to Improve Microbiome and Optimize Bariatric Surgery Outcomes (GUTERRING)

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Metabolic Syndrome Severe Obesity

Interventions Biotin supplement Fiber supplement Standard of care

Updated 5 times since 2023 Last updated: Jan 14, 2025 Started: Jul 24, 2023 Primary completion: Dec 24, 2024 Completion: Dec 24, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

end of ERC funding period

Other terminated trials from Assistance Publique - Hôpitaux de Paris

See all terminations from Assistance Publique - Hôpitaux de Paris

Other Metabolic Syndrome trials with similar outcome

Browse all Metabolic Syndrome trials

A NA clinical study on Metabolic Syndrome and Severe Obesity, this trial is terminated or withdrawn. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 5 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Feb 2025 — Present [monthly]

Terminated NA

Status: Recruiting → Terminated
Sep 2024 — Feb 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Feb 2024 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
May 2023 — Feb 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France